MedPlus Health Services Ltd: 4,552 Stores, 0% Dividend – India’s Medicine Dukaan with Discount Fever
1. At a Glance
MedPlus Health is the pharmacy chain that turned “Bhaiya, Dolo 650 hai kya?” into a ₹9,800 crore market cap empire. With 4,552 stores across India, it’s basically Big Bazaar + Apollo Pharmacy + your local chemist, but on steroids. The company sells everything from pills to Pampers, runs diagnostics, and even throws 80% discounts like it’s running an end-of-season sale at Sarojini. But before you get high on paracetamol, remember: promoters have pledged 59% of their holding – which is like mortgaging your house to run a kirana.
2. Introduction
Picture this: It’s 10 PM, you’ve got fever, your mom screams for Crocin, and your local chemist says, “Out of stock.” Enter MedPlus – with its app, its discounts, and its army of fluorescent-lit stores that feel more like mini-marts than pharmacies.
Founded by Madhukar Gangadi, MedPlus is now India’s second-largest pharmacy retailer (after Apollo). Unlike Apollo which goes for “premium healthcare vibes,” MedPlus is the street-smart cousin – focusing on discounts, tier-2/tier-3 expansion, and private label products.
The company’s strategy is basically:
Sell branded pharma (major chunk of revenue).
Push private label products (higher margins).
Use discounts to lure repeat customers.
Build diagnostics and e-commerce as side hustles.
In FY25, they added 108 net new stores, most in smaller cities. Why? Because tier-2 and tier-3 folks love discounts even more than tier-1 Instagram influencers love collagen powders.
But is this retail pharmacy giant just a glorified medical kirana chain, or is it building India’s Walgreens? That’s what we’ll crack open – scalpel in one hand, sarcasm in the other.
3. Business Model (WTF Do They Even Do?)
MedPlus operates like a multi-layered thali – pharma, FMCG, diagnostics, e-commerce.
Core Retail: 67% revenue from branded pharma. Think of it as the rice of their thali – boring, necessary, and always in demand.
Private Label: 1,164 products across pharma & FMCG. Margins here are like wedding caterer profits – fat and sweet.
Diagnostics: Three full-service centers + 100+ collection centers. Basically a testing side business – blood tests today, maybe CT scans tomorrow.
E-commerce: MedPlus Mart, Lens, Labs. Only 5% of revenue, but the 2-hour delivery promise is their “Zomato Medicine” moment.
Manufacturing: Three plants in Telangana – plastics, opticals, disinfectants. Vertical integration = cutting middlemen like a pro.
In short: MedPlus is not just a chemist shop – it’s a discount-driven, omni-channel, vertically integrated pharmacy mafia.
4. Financials Overview
Quarterly Comparison (₹ Cr.)
Metric
Jun-25 (Latest)
Jun-24 (YoY)
Mar-25 (QoQ)
YoY %
QoQ %
Revenue
1,543
1,489
1,510
3.6%
2.2%
EBITDA
131
94
136
39.4%
-3.7%
PAT
42.4
14.4
51
195%
-16.9%
EPS (₹)
3.54
1.20
4.29
195%
-17.5%
Commentary:
Revenue growth is crawling like a patient on IV drip.
EBITDA margins are holding ~8%, much better than Apollo’s drama.
PAT jumped YoY (195%) – thanks to operating leverage.
But QoQ, profits fell 17% – maybe discounts bit too hard.
5. Valuation (Fair Value RANGE only)
P/E Method: EPS ₹14.9 (annualized). Industry P/E ~55.
